Insomnia is the most common sleep disorder among adults, especially affecting individuals of advanced age or with neurodegenerative disease. Insomnia is also a common comorbidity across psychiatric disorders. Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment for insomnia;; a key component of this intervention is restriction of sleep opportunity, which optimizes matching of sleep ability and opportunity, leading to enhanced sleep drive. Despite the well-documented efficacy of CBT-I, little is known regarding how CBT-I works at a cellular and molecular level to improve sleep, due in large part to an absence of experimentally-tractable animals models of this intervention. Here, guided by human behavioral sleep therapies, we developed a Drosophila model for behavioral modification of sleep. We demonstrate that restriction of sleep opportunity through manipulation of environmental cues improves sleep efficiency and quality in multiple short-sleeping Drosophila mutants. The response to sleep opportunity restriction requires ongoing environmental inputs, but is independent of the molecular circadian clock. We apply this sleep opportunity restriction paradigm to aging and Alzheimer's disease fly models, and find that sleep impairments in these models are reversible with sleep restriction, with associated improvement in reproductive fitness and extended lifespan. This work establishes a model to investigate the neurobiological basis of CBT-I, and provides a platform that can be exploited towards novel treatment targets for insomnia.
Introduction
Insomnia is the most common sleep disorder among adults, with significant public health and economic consequences [1] [2] [3] [4] . Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line intervention for treatment of insomnia 5 . CBT-I includes a combination of modalities: behavioral therapy (restriction of sleep opportunity and stimulus control), cognitive therapy (cognitive restructuring of dysfunctional beliefs about sleep and sleep disturbances), and sleep hygiene (education pertaining to behaviors that facilitate sleep continuity). Recent work suggests that restriction of sleep opportunity alone is sufficient to gain most of the benefits of CBT-I 6 . Sleep restriction addresses a prominent clinical feature of insomnia: the mismatch between sleep opportunity and sleep ability. Patients with insomnia often expand time in bed (sleep opportunity extension) with the goal of recovering lost sleep 7 . This adaptation is thought to perpetuate insomnia in the long term by promoting the mismatch between sleep ability (low) and opportunity (high), leading to less efficient, less consolidated sleep. By restricting time in bed, sleep restriction optimizes matching of sleep ability and opportunity, leading to enhanced sleep drive (increased homeostatic pressure for sleep) and more consolidated sleep. Sleep opportunity is titrated as sleep ability stabilizes and increases. Although CBT-I has shown reliable and durable efficacy for insomnia treatment [8] [9] [10] , limited accessibility of practitioners and long duration of therapy are obstacles to broad implementation [11] [12] [13] . If behavioral sleep interventions could be studied at a molecular/cellular level, this might guide new avenues for treatment.
Insomnia is characterized by persistent difficulty initiating or maintaining sleep despite adequate sleep opportunity, along with associated daytime impairment 14 . An animal model of insomnia should recapitulate these characteristics and, in particular, display decreased ability to sleep despite environmental circumstances that normally promote sleep. Rodent models of insomnia generally involve perturbations such as stress or fear conditioning to activate arousal systems 15 , perhaps informative about acute insomnia (stress precipitated sleep loss), but less representative of chronic insomnia (conditioned sleeplessness). Neuro-imaging, EEG, and genetic work in humans lack the granularity to determine molecular mechanisms involved in onset and treatment of insomnia at a causal level. In contrast, short-sleeping Drosophila mutants are compelling models of chronic insomnia: reductions in sleep seen in numerous single gene mutants are primarily due to severely decreased sleep bout length, indicating that flies can initiate but not maintain sleep [16] [17] [18] [19] . It is unlikely that these short sleepers simply do not need sleep, as mutants exhibit shortened lifespan and/or memory deficits [16] [17] [18] [19] [20] [21] . In addition, a fly line generated by laboratory selection for insomnia-like traits 22 shares many features of human insomnia, including reduced sleep time and consolidation, along with shortened lifespan and learning deficits. These fly models might therefore serve an important role in studying insomnia etiology and treatment.
Sleep quantity and quality also decrease with aging across species, including humans [23] [24] [25] . Moreover, recent work suggests a bidirectional relationship between sleep and Alzheimer's disease (AD) pathology, where accumulation of the protein b-amyloid (Ab) worsens sleep while poor sleep accelerates Ab accumulation [26] [27] [28] . Indeed, in flies, Ab accumulation in the brain leads to reduced and fragmented sleep 29 and shortened lifespan 29, 30 . While hypnotic use is associated with increased morbidity/mortality in individuals with AD 31 , behavioral therapies show promise for improving sleep [32] [33] [34] [35] . Here, using principles of human behavioral sleep therapies in background. Canton S were obtained from E.
Kravitz. Elav-Gal4 (#458) and glass 3 (#508) were obtained from the Bloomington Drosophila Stock Center. Flies were maintained on standard yeast/cornmeal-based medium at 25 degrees on a 12hr:12hr LD cycle.
Sleep Analysis
Male and female flies were collected at 1-3 days old and aged in group housing, and flipped onto new food every 3-4 days. Flies aged 5-8 days were loaded into glass tubes containing 5% sucrose and 2% agar. Locomotor activity was monitored using the Drosophila Activity Monitoring (DAM) system (Trikinetics, Waltham MA). Activity was measured in 1 min bins and sleep was defined as 5 minutes of consolidated inactivity 36 .
Data was processed using PySolo software 37 . Sleep latency (SL) was determined by time (minutes) until first sleep episode following lights off. Wake after sleep onset (WASO) was calculated as the minutes of wake after initiation of the first sleep episode until end of the dark period. Activity index was calculated as the average number of beam breaks per minute of wake time. For all experiments, the first day of data following loading was discarded. Male flies were used for all experiments unless otherwise specified.
Dark Time Extension
Five to eight day old flies were loaded into incubators and 2 days of baseline data were collected at 12:12 LD (9AM-9PM) cycles to compare populations at baseline. On day 3, light schedules either remained at 12:12 LD or shifted to a 10:14 LD or 8:16 LD cycle.
Sleep data was collected for 4 additional days. Under 10:14 LD, incubators were dark from 8PM-10AM, while under 8:16 LD, incubators were dark from 7PM-11AM. Day 4-5 of data collection was used for analysis.
Dark Time Restriction
Five to eight day old flies were loaded into incubators and 2 days of baseline data were To evaluate the effects of tapering dark time, light schedules were changed to 18:6, 16:8 or 14:10 LD conditions, or the tapered restriction schedule above. 18:6 LD was compared to the tapered condition on Day 6, 16:8 LD was compared on day 8, and 14:10 LD was compared on day 10.
Temperature Change
Five to eight day old flies previously entrained to 12:12LD conditions were loaded into incubators. Two days of baseline data were collected under DD (constant dark) conditions at 26°C to compare populations at baseline. On day 3, temperatures were reduced to 18°C during the following periods (otherwise at 26°C): 1AM-5AM for days 3-4, 12AM-6AM for days 5-6, 11PM-7AM for days 7-8, and 10PM to 8AM for days 9-10.
The 2nd day of each new temperature cycle was used for analysis.
Aging
Male and female flies were collected at 1-3 days old and group housed at a density of approximately 10 male and 10 female flies per vial. Flies were maintained on a dextrose-based food mixture, containing 11.7% (wt/vol) dextrose, 0.6% corn meal, and 0.3% yeast, and transferred to fresh food every 3-4 days. If fly density in vials became <10 flies, vials were combined to maintain original density. Flies were assayed for sleep and egg laying behaviors at 53 days post-eclosion.
Egg Laying Assay
Egg laying assays were performed in 60 mm Petri dishes. Dishes were first filled with 8 ml molten dextrose-based food which was allowed to cool and solidify. Dishes were visually examined to ensure that the surface was smooth. Twenty aged female flies were placed upon a dextrose dish in an embryo collection cage (Genesee Scientific, cat#: 59-100). Dishes were replaced after 24 hours, and 3 consecutive days were averaged for each replicate experiment.
Longevity Assay
Ten replicate vials, each containing 10 male and 10 female flies, were established for each condition. Flies were transferred to fresh dextrose-based food vials every 2---3 days, at which time dead flies were removed and recorded. Assays were conducted at least twice per genotype.
Statistical Analysis and Data Reproducibility
Analysis was done using Prism (GraphPad Software). ANOVA with Tukey's test was used in Figure  1C Figure  5A . Log-rank test was used in Figure  5J and
Supplementary
Figure 5B. For significance: *p≤0.05;; **p<0.01;; ***p<0.001. Each experiment was generated from a minimum of 3 independent biological replicates.
Samples were allocated based on genotype or experimental manipulation and statistics performed on aggregated data. Results
Sleep opportunity extension impairs sleep quality in Drosophila
In aiming to model human behavioral sleep interventions in Drosophila, we first asked whether mismatch of sleep opportunity and ability degrades sleep quality in fruit flies ( Fig.  1A) , as it does it humans. Darkness is a powerful sleep-promoting cue in humans and Drosophila, and wild type flies raised on a 12hr:12hr light:dark (LD) cycle exhibit high sleep efficiency (sleep time divided by total sleep opportunity) over the dark period 38, 39 . To control sleep timing and experimentally expand sleep opportunity, we examined sleep in wild type flies (iso 
Sleep opportunity restriction enhances sleep in short-sleeping mutants
If sleep extension results in analogous behavioral responses in humans and flies, can sleep opportunity restriction potentiate sleep efficiency in Drosophila short-sleeping mutants, as it does in humans with insomnia ( Fig.  2A,B) ? We first examined fumin mutants, which lack a functional dopamine transporter and sleep ~200-300 minutes per day, representing a 70-80% reduction from wild type levels ( Fig.  2C ) 42 . In humans with insomnia undergoing CBT-I, the initial amount of sleep restriction is determined based on an individual's total sleep time (TST);; a titration procedure is then used to increase sleep opportunity as sleep is consolidated and becomes more efficient 43 . Applying this approach to fumin mutants, sleep time was compressed by initially contracting dark time to 4 hours, followed by titration of sleep opportunity by expanding the dark period by 2 hours every other day (Fig.  2B) . Using this paradigm, we observed a threefold increase in sleep efficiency, with maximal improvement at 6-8 hours sleep opportunity (Fig  2C-F) . Fig.  2A-D) . Interestingly, TST with compression of the dark period was increased above 12:12 LD conditions (Fig.  2G) , despite reduced opportunity.
The enhancement in sleep efficiency and TST was driven primarily by an increase in the number of sleep bouts initiated with sleep opportunity restriction ( To test whether enhanced sleep following sleep opportunity restriction is specific to fumin mutants, we next examined this paradigm in other mutants with distinct genetic lesions underlying the short-sleep phenotype: sleepless, redeye, and wide awake 17, 44, 45 .
The dark period was restricted based on average TST for each mutant under 12:12 LD cycles. As with fumin flies, we found that restriction of sleep opportunity in each mutant increased sleep efficiency and consolidation, and reduced SL and WASO (Fig.  3,   Supplementary  Fig.  3 ). TST was largely unchanged with sleep compression (Supplementary  Fig.  3 ), suggesting that the primary improvement is in sleep quality, consistent with CBT-I findings in humans [46] [47] [48] . These results demonstrate that behavioral sleep modification can be applied across a variety of short-sleep etiologies, and indicate there is a ceiling beyond which sleep cannot be improved (i.e., sleep mutants cannot be fully restored to wild type sleep levels). Together, our data establish a paradigm for behavioral sleep modification in flies, and suggest that sleep ability is plastic in Drosophila short-sleeping mutants.
Response to sleep restriction requires ongoing environmental cues.
All of the short-sleeping mutants we examined have normal molecular and behavioral rhythms under 12:12 LD conditions 17, 42, 44, 45 , but aberrant light cycles affect function of the molecular clock. To determine whether enhanced sleep following sleep opportunity restriction is clock-dependent, we generated per
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;;fumin double mutants that lack a functional molecular clock in addition to exhibiting a short-sleep phenotype.
With dark period compression, we observed that increased sleep efficiency and consolidation persist, indicating that sleep restriction is clock-independent (Fig.  4A-D Fig.  4E-H) . Restriction of sleep opportunity with coincident darkness and low temperature yielded similar increased sleep efficiency to dark or low temperature alone ( Supplementary  Fig.  4A,B) , suggesting that either cue is sufficient for the maximum sleep improvement in fumin mutants.
How do other features of behavioral sleep modification in humans function in our fly model? First, in humans, behavioral sleep modification initiates with the greatest restriction of sleep opportunity and the goal of enhancing sleep drive/stabilizing sleep ability. This is followed by increased periods of sleep opportunity (titration) that would not have yielded efficient sleep at the outset. To test whether the titration paradigm is necessary in flies, we examined gradual extension of the dark period from 4 to 10 hours in comparison to direct initiation of sleep opportunity restriction at either 6, 8, or 10 hours in fumin mutants. We found that enhanced sleep efficiency and sleep consolidation was similar whether tapered from 4 hours or restricted directly to 6, 8, or 10 hours (Fig.  4I,  Supplementary  Fig.  4C,D) . Second, improved sleep with sleep restriction in humans can take days to manifest, as sleep drive builds. We found in
fumin mutants that the first day of sleep opportunity restriction (whether 4 or 6 hours)
did not induce a maximal improvement in sleep efficiency or SL compared to 12:12 LD conditions;; improvement reliably maximized by day 3 of restriction ( Supplementary  Fig.   4E ,F), suggesting that homeostatic sleep drive has to build over time. Third, adherence to the components of CBT-I, including sleep restriction, is strongly related to treatment outcome 53 . We asked whether enhanced sleep with dark period compression persists with termination of sleep restriction. We restricted sleep opportunity in fumin mutants to 6 hours (18:6 LD), and then shifted to constant dark (DD) to test if increased sleep efficiency continues in the absence of all light cues. With this manipulation, we found a regression of sleep efficiency back to baseline (Fig.  4J) . Finally, humans with insomnia who undergo behavioral sleep modification might restrict sleep from the beginning of the night, end, or both depending on patient preference. We initially modeled Drosophila sleep restriction by limiting sleep opportunity from both start and end of the night (e.g., Zeitgeber Time (ZT) 15-21 for 6 hours of restriction). To test whether this behavioral paradigm depends on timing of sleep restriction or only total amount, we limited sleep opportunity to either the first 6 (ZT 12-18) or last 6 (ZT 18-24) hours of the subjective night. We observed no significant difference in sleep efficiency or SL across these conditions (Fig.  4K,  Supplementary  Fig.  4G ), indicating that the amount of sleep opportunity, not the timing, determines response.
Our results suggest that blocking sensory processing of LD cues should occlude the response to sleep restriction with dark period compression. Flies process light through canonical visual pathways as well as other light sensors such as CRYPTOCHROME (CRY) 54 ;; genetic disruption of both of these pathways renders 54, 55 . We generated glass;;fumin double mutants, which lack all functional eye components and are shortsleepers. These double mutants exhibited no change in sleep efficiency or SL with dark period restriction (Fig.  4M-O) , indicating that a functional eye is necessary for induction of sleep restriction. CRY is a UV- and blue light-sensitive protein that communicates light information to the circadian system [56] [57] [58] . To test whether CRY plays a role in the response to sleep opportunity restriction, we generated cry
Drosophila insensitive to LD cycling and behavioral arrhythmicity
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:fumin double mutants.
These flies exhibited an attenuated response to sleep restriction (Fig.  4L,N,O) , suggesting that maximal increases in sleep efficiency with restriction of the dark period utilize multiple light-processing systems. Together, these data demonstrate that sleep restriction has a direct reliance on environmental cues to produce its effect regardless of prior experience, and that sleep opportunity restriction in flies does not cause a longlasting change in the absence of these cues. Fig.  5A ). To assess behavioral consequences of consolidating sleep in aged flies, we examined reproductive fitness following sleep opportunity restriction. Aged female flies normally exhibit a dramatic reduction in reproductive output 64 , and reproductive output is also impaired with sleep deprivation 65 .
Sleep restriction improves sleep in aging and
We tested whether such decrements are modifiable with improved sleep. We assessed egg laying behavior after 5 nights of sleep opportunity restriction in 53 day old mated female flies, and found that flies with improved sleep laid significantly more eggs in a 24-hour period than controls (Fig.  5B) . This increase was not simply due to exposure to cool temperatures, as addition of an equivalent low temperature period during the day under 12:12 LD conditions was indistinguishable from control flies. These results raise the possibility of potential behavioral benefits to improved sleep in aged flies following restriction of sleep opportunity.
Sleep quality degrades with normal aging, but disruptions to sleep are also increasingly appreciated in neurodegenerative processes like Alzheimer's disease (AD) 66 . Several models of AD have been established in Drosophila, including those based on expression of aggregating b-amyloid (Ab) peptides 67, 68 ;; Aβ accumulation results in decreased and fragmented sleep, while sleep deprivation increases Aβ burden 29 . We examined sleep following pan-neuronal expression of AbArctic, which carries a mutation to induce enhanced aggregation 67 . Consistent with previous work 29 , we observed reduced night TST and increased sleep fragmentation in 7-10 day old male flies with pan-neuronal AbArctic expression under 12:12 LD cycles (Fig.  5C,E,F,I ).
Sleep was less efficient, due to a reduction in sleep bout duration and increase in number of sleep bouts (Fig.  5D-F) ;; WASO was likewise increased with pan-neuronal AbArctic expression, though SL was unaffected (Fig.  5G,H) . We next examined whether sleep degradation related to Ab accumulation is reversible with sleep opportunity restriction using dark period compression. We found this manipulation restored sleep efficiency, sleep bout length, and number of sleep bouts back to control levels ( Fig.  5D-F) ;; WASO was also normalized, and SL was shortened (Fig.  5G,H) . TST was unchanged with restriction of sleep opportunity, but flies were able to achieve the same amount of sleep in the compressed window (Fig.  5I) . Thus, manipulation of environmental cues is sufficient to improve sleep despite pan-neuronal Ab aggregation. Does enhancement of sleep quality in this model of AD have other beneficial effects? AbArctic flies exhibit severly curtailed lifespan 29 , so we tested whether correcting sleep can affect longevity. Comparing flies expressing AbArctic panneuronally under either 12:12 LD or dark-restricted conditions, we found that sleep opportunity restriction was associated with a significant extension of lifespan in both males and females (Fig.  5J,  Supplementary  Fig.  5B ). This longevity extension was not due to changes in the LD cycle, as genetic controls showed no alteration in longevity with sleep opportunity restriction. Taken together, these data suggest that behavioral sleep modification mitigates Ab-related sleep disturbances and shortened lifespan.
Discussion
CBT-I is the first-line treatment for insomnia, offering advantages over existing pharmacotherapies with regard to safety and durability of response 33 . However, CBT-I is limited by obstacles to broad implementation [11] [12] [13] . Research in Drosophila has yielded numerous insights into basic sleep neurobiology, and here, we have leveraged this system to develop a tractable experimental model of sleep restriction therapy for insomnia. We find that mismatch of sleep opportunity and ability degrades sleep quality in flies, as in humans. Surprisingly, compression of sleep opportunity in short-sleeping genetic mutants improves sleep efficiency along with multiple measures of sleep quality.
We apply this paradigm to normal aging and neurodegeneration, both of which are associated with impaired sleep, and find that behavioral sleep modification restores sleep quality and extends lifespan. These data establish a new platform for deciphering mechanistic principles of a behavioral sleep therapy that improves sleep across species.
Previous work has argued that short-sleeping flies are a compelling model for studying human insomnia 22, 69 . Single gene mutants such as those tested here 17, 42, 44, 45 , as well as a line generated by laboratory selection over many generations as the core insomnia treatment modality. Indeed, the Spielman model for insomnia (also known as the 3P model) identifies predisposing (e.g., genetic) and precipitating factors (e.g., acute stressor) that lead to acute insomnia, with perpetuating factors (e.g., sleep extension) that shift acute insomnia to chronic 73, 74 . This model has served as the basis for using sleep restriction in humans to target sleep extension (a perpetuating factor).
Our results raise the possibility that sleep restriction also targets predisposing genetic factors, by better matching intrinsic sleep ability with opportunity. In other words, humans with a genetic predisposition to insomnia might be sleep "over-extended" even if sleep opportunity appears normal;; restriction of sleep opportunity would therefore increase sleep efficiency and perhaps potentiate sleep ability.
Poor sleep has long been appreciated as a comorbidity of aging and neurodegeneration 25, 28 , but more recently identified as a potential modifiable risk factor for neurodegenerative disease progression [26] [27] [28] . In flies, pharmacologic and genetic approaches to improve sleep have been shown to ameliorate memory deficits in an Alzheimer's disease model 75 ;; similarly, altering the sleep-Ab interaction by modulating neuronal excitability with a pharmacotherapy prolongs lifespan in Ab-expressing flies 29 .
We find that increased sleep efficiency through compression of sleep opportunity is alone sufficient to extend lifespan in Ab-expressing flies. Intriguingly, this work suggests that behavioral approaches to treating insomnia could slow progression of disease, consistent with evidence in humans demonstrating that CBT-I in older adults with mild cognitive impairment improves cognitive function Biol. 16, 4182-8 (1996) . 
